English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 5 May 2022, 04:05 HKT/SGT
Share:
    

Source: Avantor
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry

Singapore, May 5, 2022 - (ACN Newswire) - Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution Hub in Singapore, by integrating its existing distribution facility with new manufacturing operations. The new Hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year.

Avantor announced it will create a new Manufacturing and Distribution Hub in Singapore by integrating its existing distribution facility with new manufacturing operations.

"The Singapore Manufacturing and Distribution Hub will enable Avantor to better serve the fast-growing Asia Pacific Biopharma market by facilitating shorter lead times, enhancing supply chain security and increasing capacity in the region," said Christophe Couturier, Executive Vice President, AMEA, Avantor. "The Hub will boost regional innovation and serve as an industry benchmark for Singapore and Asia Pacific's global quality and regulatory standards, and demonstrates Avantor's commitment to growing our presence in the region."

The new Hub will provide a range of services including quality control and inventory management expertise, and feature cGMP manufacturing suites and testing labs for process ingredients and excipients.

About Avantor

Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.

For more information, visit https://news.avantorsciences.com/home and find us on:
LinkedIn: https://www.linkedin.com/company/avantorinc/
Twitter: https://twitter.com/Avantor_News
Facebook: https://www.facebook.com/Avantorinc/

Regional Media Contact
Christina Koh
Director, Communications - AMEA
Avantor
M: +65 9720 0169
Christina.Koh@avantorsciences.com

Topic: Press release summary
Source: Avantor

Sectors: Daily News, BioTech, Healthcare & Pharm, Local Biz, MedTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 
Avantor Links

http://www.avantorsciences.com

https://www.facebook.com/Avantorinc/

https://twitter.com/Avantor_News

https://youtu.be/mfjZEfO_RVM

https://www.linkedin.com/company/avantorinc/

Avantor Related News
Mar 21, 2024 09:00 HKT/SGT
Avantor Wins Five Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2024
July 11, 2023 13:00 HKT/SGT
Avantor Inaugurates Expanded Singapore Hub
Apr 3, 2023 12:00 HKT/SGT
Avantor Named Best Bioprocessing Supplier in Cell and Gene Therapy at the Biopharma Excellence Awards India Edition
Mar 16, 2023 09:00 HKT/SGT
Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards
Aug 24, 2022 07:55 HKT/SGT
Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575